Led by OrbiMed Advisors, an investment management firm focused on the healthcare sector, Caduceus Private Investment funds invest primarily in US mid and late stage private
life science companies and medical technologies.
In a recent Viewpoint interview, Riley Doyle, CEO and Technical
Lead at Desktop Genetics, a rapidly growing biotech software
company based in London, spoke to us about the challenge faced
by many new
life science startups: